Verastem (VSTM) Other Accumulated Expenses (2011 - 2026)
Verastem (VSTM) posted quarterly Other Accumulated Expenses of $857000.0 for Q1 2026, down 49.79% year-over-year from $1.7 million in Q1 2025, and down 71.58% quarter-over-quarter from $3.0 million in Q4 2025.
Analysis
Verastem (VSTM) Other Accumulated Expenses (2011 - 2026) Analysis & Trends
Verastem's Other Accumulated Expenses history runs 16 years deep, the most recent figure standing at $857000.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses fell 49.79% year-over-year to $857000.0; the TTM figure through Mar 2026 stood at $857000.0 (down 49.79% YoY), while the FY2025 annual figure was $3.0 million, up 805.41% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $857000.0, down from $3.0 million in the prior quarter.
- The five-year high for Other Accumulated Expenses was $12.6 million in Q2 2022, with the low at $183000.0 in Q2 2025.
- The 5-year median for Other Accumulated Expenses is $1.2 million (2024), against an average of $3.2 million.
- The sharpest annual moves came in 2024 and 2025: Other Accumulated Expenses plunged 92.31% in 2024, then soared 805.41% in 2025.
- Verastem's Other Accumulated Expenses stood at $996000.0 in 2022, then climbed by 8.13% to $1.1 million in 2023, then plunged by 69.08% to $333000.0 in 2024, then jumped by 805.41% to $3.0 million in 2025, then plunged by 71.58% to $857000.0 in 2026.
- Business Quant data shows VSTM's Other Accumulated Expenses at $857000.0 in Q1 2026, $3.0 million in Q4 2025, and $2.0 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.90 Mn |
| Mar 31, 2026 | 3.14 Mn |
| Dec 31, 2025 | 3.02 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 1.78 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.28 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 9.05 Mn |
| Jun 30, 2023 | 7.70 Mn |
| Mar 31, 2023 | 8.95 Mn |
| Dec 31, 2022 | 996,000.00 |
| Sep 30, 2022 | 8.16 Mn |
| Jun 30, 2022 | 12.62 Mn |
| Mar 31, 2022 | 9.37 Mn |
| Dec 31, 2021 | 9.31 Mn |
| Sep 30, 2021 | 7.38 Mn |